The Effect of Cilostazol in reducing venous anastomosis stenosis of upper extremity ArterioVenous Hemodialysis Graft †A triple-blinded Randomized controlled trial.
Not Applicable
- Conditions
- arteriovenous graft ,venous anastomosis stenosisvenous anastomosis stenosis ,cilostazol
- Registration Number
- TCTR20190328003
- Lead Sponsor
- ramathibodi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
ESRD patient
age 18-90 years
need hemodialysis
new created upper extremities Arteriovenous graft
Exclusion Criteria
active cardiac problem
cilostazol drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method venous anastomosis stenosis 1 ,3, 6 months ultrasound base
- Secondary Outcome Measures
Name Time Method patency 1 ,3, 6 months clinical,steal syndrome 1 ,3, 6 months clinical,complication 1 ,3, 6 months clinical